SPEECH-PROCESSING-SOLU
21.6.2016 09:03:13 CEST | Business Wire | Press release
Speech Processing Solutions , the international leader in professional dictation, just launched a new dictation microphone. The improved SpeechMike Premium Touch comes with an innovative touch sensor for optimized and ergonomic navigation, including reduced thumb movement, and an enhanced barcode scanner for quick and easy file association. In addition to these user-friendly updates, the device can scan even more types of bar- and QR codes than its predecessor. The SpeechMike Premium Touch dictation microphone lets healthcare, legal and business professionals dictate their documents, saving them time and resources by allowing them to accomplish their core tasks – benefits that can be directly passed on to their clients.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20160621005179/en/
Renowned for its superior microphone quality
The Philips SpeechMike Premium has long been known for its crystal-clear recording quality, and sets the standard for dictation devices worldwide. The free-floating microphone guarantees that almost no background, touch, click, air or structure-borne noise is recorded. “The SpeechMike Premium has established itself as THE benchmark for professional dictation microphones in the industry,” said Dr. Thomas Brauner, CEO of Speech Processing Solutions. “Unrivaled recording quality and noise canceling capabilities, as well as its perfect ergonomics and the antimicrobial surface make it a perfect tool for professional dictation users. These functions are especially helpful for attorneys and medical personnel.”
Focus on content
The new device is equipped with a durable touch sensor. Users can accurately control their mouse cursor using the new SpeechMike Premium Touch. This allows them to easily use and navigate within applications while recording, without having to switch between the mouse and microphone .
Less frequently used functions are placed above or below the sensor, and clearly delineated. Clearly marked distances and different shapes are perfect for operating the device without constantly looking down. Even the Premium Touch’s flip side is optimized for ergonomic and easy use: “Trigger” and “Command” buttons are placed just right to prevent unwanted activation. The key is to focus on content rather than complicated usage instructions. Configurable functions permit a personalized workflow, and an integrated movement sensor that mutes the microphone when not in use adds a finishing touch. “The new features guarantee smooth and convenient operation, even when recording over longer periods of time every day. The Premium Touch can also read more barcodes than its predecessor, allowing end users to quickly categorize and associate client and patient data. The results are enhanced security and potential cost savings,” said Brauner.
Speech to text made easy
Philips SpeechMike Premium Touch makes going from recording your voice to a written document a simple process. The dictation microphone is easy to integrate into users’ IT infrastructures, and works in harmony with existing software, both in large hospitals or small businesses. Thanks to the excellent recording quality, Philips SpeechMike Premium Touch is perfectly suited for transcription, whether by an assistant, speech recognition software, or Philips dictation workflow solutions such as SpeechLive and SpeechExec.
Philips SpeechLive dictation solution
Philips workflow software creates a smooth and safe work cycle between authors and transcriptionists. “Philips SpeechLive is a perfect solution for people like myself, who are on the go a lot. It guarantees a reliable and safe transmission of dictations, regardless of what time it is” explained Dr. Peter Klein, partner at the international law firm PFKA, in Austria adding that: “The offered transcription service is another advantage, particularly in foreign languages such as French, as it virtually increases our office’s capacity.”
For more information on the Philips SpeechMike Premium Touch (SMP3700/3800 series) visit: www.philips.com/dictation
Philips is now offering a free 30-day SpeechLive trial including 10 free transcription minutes at: www.speechlive.com
About Speech Processing Solutions
Speech Processing Solutions is the global number one in professional dictation. Founded in Austria in 1954 as part of Philips, the company has been the driving force in speech-to-text innovations for over 60 years. Always striving for excellence and putting emphasis on outstanding quality, the company has designed groundbreaking products, such as the portable Philips Pocket Memo voice recorder , the Philips SpeechMike Premium dictation microphone and the Philips SpeechExec dictation recorder app for smartphones. The latest innovation, Philips SpeechLive , makes dictation quicker and more convenient than ever before, by bringing secure dictation workflow to the cloud and enabling seamless speech-to-text with the new speech recognition service. With solutions perfectly tailored to individual industry needs, Speech Processing Solutions has helped millions of satisfied customers around the globe save time and resources, allowing them to work as efficiently as possible.
Connect with Speech Processing Solutions on:
Facebook: http://www.facebook.com/philipsvoicetracer
Twitter @speech_com: http://www.twitter.com/speech_com
YouTube: http://www.youtube.com/philipsdictation
LinkedIn: http://www.linkedin.com/company/speech-processing-solutions
View source version on businesswire.com: http://www.businesswire.com/news/home/20160621005179/en/
Contact:
Speech Processing Solutions
Lea Pachta
lea.pachta@speech.com
Tel:
+43 1 60529-1744
www.philips.com/dictation
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Pacific Defense Awarded U.S. Marine Corps Contract for Next Generation Electronic Warfare Prototype29.4.2026 13:00:00 CEST | Press release
Award advances SOSA/CMOSS mission system ecosystem and informs future EW fielding decisions Pacific Defense has been awarded a 12-month rapid prototyping contract by the U.S. Marine Corps Systems Command (MARCORSYSCOM), Program Manager for Tactical Communications and Electronic Warfare (PM TCE) to support next-generation electronic warfare (EW) capability evaluation. The effort will assess Modular Open Systems Approach (MOSA) Electronic Warfare (EW) mission systems and their potential in modernizing USMC capabilities. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260429918712/en/ Pacific Defense's Next Generation Electronic Warfare System enables rapid integration of new hardware and software into a common chassis, accelerating capability insertion while reducing vendor lock and lifecycle costs. Under the contract, Pacific Defense will deliver SOSA/CMOSS-aligned mission systems to enable vehicle-based experimentation by U.S
Visa Accelerates Stablecoin Momentum: Adding Five Blockchains for Settlement29.4.2026 13:00:00 CEST | Press release
Stablecoin settlement pilot sees record growth 50% quarter over quarter, reaching $7B run rate. Today, Visa (NYSE: V) announced that it is adding five blockchains to its global stablecoin settlement pilot, expanding how issuers and acquirers can settle with the network. As stablecoins move into mainstream payment flows, Visa’s stablecoin settlement pilot now supports nine blockchains and has reached a $7 billion annualized stablecoin settlement run rate, up 50% since last quarter. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260429143049/en/ Visa is adding support for five additional blockchains, further expanding its multi-chain settlement capabilities. “Our partners are building in a multi-chain world, and they expect their options to reflect that reality,” said Rubail Birwadker, Global Head of Growth Products and Strategic Partnerships, Visa. “Expanding our stablecoin settlement pilot program to more blockchains means o
U.S. FDA Grants Priority Review to BeOne Medicines’ TEVIMBRA in First-Line HER2+ GEA29.4.2026 12:00:00 CEST | Press release
TEVIMBRA plus ZIIHERA and chemotherapy regimen delivered statistically significant median OS of 26.4 months, an unprecedented result in this challenging diseaseResults from the global Phase 3 HERIZON-GEA-01 study demonstrate potential to change clinical practice in advanced HER2+ gastroesophageal adenocarcinoma BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the U.S. Food and Drug Administration (FDA) has granted Priority Review to a supplemental Biologics License Application (sBLA) for TEVIMBRA® (tislelizumab) in combination with ZIIHERA® (zanidatamab) and chemotherapy for the first-line treatment of unresectable locally advanced/metastatic HER2-positive (HER2) gastric, gastroesophageal junction, or esophageal adenocarcinoma. The FDA has also granted Breakthrough Therapy Designation to the regimen of ZIIHERA in combination with fluoropyrimidine- and platinum-containing chemotherapy, with and without TEVIMBRA, in this indica
European Commission (EC) Approves Henlius and Organon’s POHERDY® (pertuzumab), the First Approved Biosimilar to PERJETA (pertuzumab) in Europe29.4.2026 11:30:00 CEST | Press release
Shanghai Henlius Biotech, Inc. (2696.HK), and Organon (NYSE: OGN) today announced the European Commission (EC) has granted marketing authorization for POHERDY® (pertuzumab) 420 mg/14 mL injection for intravenous use, the first and only approved biosimilar to PERJETA (pertuzumab) in Europe, for all indications of the reference product.1 This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260429686426/en/ “As the first, and currently the only, pertuzumab biosimilar in Europe, the EC’s approval of POHERDY marks an important milestone in expanding access to treatments for patients with certain HER2-positive breast cancers, particularly as breast cancer is the most commonly diagnosed cancer among women in the European Union,” said Joe Azzinaro, Vice President, Global Commercial Lead Biosimilars, at Organon.2,3 “Organon’s growing global portfolio of biosimilars reinforces our ongoing commitment to supporting the sustainability of healt
Andreas Goppelt Appointed Managing Director of OrphaCare29.4.2026 10:27:00 CEST | Press release
OrphaCare, a global specialist for the development and marketing of medical devices for drug delivery and part of the AOP Health Group, has appointed Andreas Goppelt as its new Managing Director, succeeding Georg Fischer. In this role, the seasoned medical device expert will focus on broadening the company’s strategic scope and driving its next phase of growth. OrphaCare plays a key role in supporting AOP Health’s integrated therapies approach, and the Group’s long-term expansion. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260429303533/en/ Portrait Andreas Goppelt, Managing Director OrphaCare (copyright: AOP Health/Studio Koekart) Andreas Goppelt brings more than 25 years of leadership experience across MedTech, biotechnology and the pharmaceutical industry. He has a proven track record of driving innovation, scaling global organizations, and delivering growth in highly regulated healthcare environments. In his new role,
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom